AXL and nasopharyngeal carcinoma: A recent study demonstrated that Axl small-molecule inhibitor hinders glioblastoma growth, migration, and invasion in vitro and in vivo [34], thus highlighting the need for targeting Axl specifically in NPC diagnosis and treatment.